%0 Journal Article
%T CD40 Ligand-Modified Chimeric Antigen Receptor T Cells Enhance Antitumor Function by Eliciting an Endogenous Antitumor Response
%J -
%D 2019
%R https://doi.org/10.1016/j.ccell.2019.02.006
%X £¿ CD40L + CAR T cells kill antigen-negative tumor cells through CD40/CD40L interactions £¿ CD40L + CAR T cells improve antitumor response compared with second-generation CAR T cells £¿ CD40L + CAR T cells license APCs in vivo to aid in antitumor response £¿ Licensed APCs prime non-CAR T cells to recognize tumor cells and produce cytokine
%U https://www.cell.com/cancer-cell/fulltext/S1535-6108(19)30101-1